MarketBeat · 4. Aug. 2026, 16:04
Arvinas Q2 Earnings Call Highlights
Key Points Interested in Arvinas, Inc.? Here are five stocks we like better. Arvinas is shifting resources to early-stage oncology and neurology programs after the FDA approved VEPPANU, the